NEUTRALIZATION OF RECOMBINANT HIRUDIN - SOME PRACTICAL CONSIDERATIONS

被引：15

作者：

FAREED, J ^{[1
]}

WALENGA, JM ^{[1
]}

HOPPENSTEADT, D ^{[1
]}

IYER, L ^{[1
]}

PIFARRE, R ^{[1
]}

机构：

[1] LOYOLA UNIV,MED CTR,DEPT THORAC & CARDIOVASC SURG,MAYWOOD,IL 60153

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1991年 / 17卷 / 02期

关键词：

D O I：

10.1055/s-2007-1002602

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：137 / 144

页数：8

共 11 条

[1]

CHESEBRO JH, 1989, ANGIO ARCH, V18, P9

[2]

FAREED D, 1989, FASEB Journal, V3, pA308

[3] HEPARIN, ITS FRACTIONS, FRAGMENTS AND DERIVATIVES - SOME NEWER PERSPECTIVES [J].

FAREED, J .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (01) :1-9

[4]

FAREED J, 1989, FASEB Journal, V3, pA328

[5]

FAREED J, 1989, ANGIO ARCH, V18, P24

[6]

FAREED J, 1989, BIOLCLIN HEMATOL, V11, P13

[7]

Glusa E, 1988, Folia Haematol Int Mag Klin Morphol Blutforsch, V115, P88

[8] HEPARIN ENHANCES THROMBIN-STIMULATED PROSTAGLANDIN-I2 PRODUCTION BY CULTURED ENDOTHELIAL-CELLS [J].

ITOH, F ;

KAJI, T ;

HAYAKAWA, Y ;

OGUMA, Y ;

SAKURAGAWA, N .

THROMBOSIS RESEARCH, 1990, 57 (04) :481-488

[9]

MARKWARDT F, 1984, THROMB HAEMOSTASIS, V52, P160

[10]

WALENGA J M, 1990, Drugs of the Future, V15, P267

← 1 2 →